Answer
No. Obinutuzumab is a targeted monoclonal antibody against CD20, although it may be combined with chemotherapy or other immunosuppressive treatment.
Sources for this answer
- Gazyvaro 1,000 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.